92437-43-9 Usage
Uses
Used in Pharmaceutical Industry:
2-METHYL-1-PHENYL-1H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID is used as a precursor in the synthesis of piperazine derivatives, which are known as MAGL (monoacylglycerol lipase) inhibitors. These inhibitors play a crucial role in the development of drugs targeting various medical conditions, including neurological disorders and pain management. 2-METHYL-1-PHENYL-1H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID's ability to form stable and bioactive piperazine derivatives makes it a valuable component in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 92437-43-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,4,3 and 7 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 92437-43:
(7*9)+(6*2)+(5*4)+(4*3)+(3*7)+(2*4)+(1*3)=139
139 % 10 = 9
So 92437-43-9 is a valid CAS Registry Number.
InChI:InChI=1/C15H12N2O2/c1-10-16-13-9-11(15(18)19)7-8-14(13)17(10)12-5-3-2-4-6-12/h2-9H,1H3,(H,18,19)
92437-43-9Relevant academic research and scientific papers
AGENT FOR TREATMENT OR PREVENTION OF DISEASES ASSOCIATED WITH ACTIVITY OF NEUROTROPHIC FACTORS
-
, (2012/04/17)
A compound depicted by the formula below, or a pharmaceutically acceptable salt or solvate thereof. wherein, R1 represents (1) a C3-6 alkyl group,(2) a C1-6 alkyl group substituted with one or more substituent group(s) sel
BENZIMIDAZOLE AND AZA-BENZIMIDAZOLE CARBOXAMIDES
-
Page/Page column 30; 32, (2010/05/14)
This invention provides compounds of Formula I which are PAFR antagonists: I and the pharmaceutically acceptable salts thereof. The compounds are useful for treating PAF-mediated disorders, and can be used in methods for treating atherosclerosis and preve
